Skip to main content
UniHealth

Doctor search

Robert Stuart Negrin, MD

Hematopoietic Cell Transplantation and Cellular Therapy · Stanford

NPI 1285791756

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
13
2 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

13 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Negrin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

13 of 13 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G55538 · Current

Licensed to practise in California · since 1985 · expires 2027-03-31 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$25,276

Medicare paid this office $25,276 for 57 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes32$16,763$105
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes14$1,865$117
Long return visit (40+ min)13$1,854$116
Hospital discharge day management, 30 minutes or less13$1,038$74

Who their Medicare patients are

57 Original Medicare patients in 2024. Average age 70 · Women 54% · Also on Medicaid 25% · Health risk score 3.35. Above the middle of the specialty; the typical hematopoietic cell transplantation and cellular therapy clinician is at 2.85.

Conditions among them: High blood pressure 63% · Chronic kidney disease 25% · Atrial fibrillation 25% · Diabetes 23% · Depression 23%.

The office billed $96,527, Medicare allowed $32,769 and paid $25,276; for 237 services of 8 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202457237703.35$96,527$25,276
202341164692.96$68,238$18,025
202244166672.90$65,715$16,882
20202077692.64$31,631$7,455
201945208663.35$74,545$18,549
201863251673.42$88,766$23,519
201750187652.96$60,018$16,737
201651201633.40$76,867$18,574
201537143663.38$47,664$12,790
201448219623.66$75,572$20,990
201341125633.22$42,959$11,082

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes18$9,393$104
Long return visit (40+ min)20$5,718$133

2022: 3 services

Original Medicare services billed in 2022
Long return visit (40+ min)22$5,918$121
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$5,217$93
Hospital discharge day management, 30 minutes or less12$799$67

2020: 1 service

Original Medicare services billed in 2020
Long return visit (40+ min)13$2,421$97

2019: 4 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$9,255$93
Long return visit (40+ min)16$2,423$97
Return visit (30+ min)11$1,077$67
Hospital discharge day management, 30 minutes or less12$1,013$68

2018: 4 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes28$12,440$94
Long return visit (40+ min)25$5,339$95
Return visit (30+ min)13$989$66
Hospital discharge day management, 30 minutes or less13$869$67

2017: 3 services

Original Medicare services billed in 2017
Long return visit (40+ min)22$5,573$96
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes19$5,294$91
Return visit (30+ min)12$1,291$65

2016: 3 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$9,166$93
Long return visit (40+ min)15$3,964$94
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes12$1,157$64

2015: 2 services

Original Medicare services billed in 2015
Long return visit (40+ min)19$3,376$96
Return visit (30+ min)16$1,474$70

2014: 2 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes22$10,166$92
Long return visit (40+ min)17$6,446$95

2013: 2 services

Original Medicare services billed in 2013
Long return visit (40+ min)13$2,651$88
Return visit (30+ min)19$1,559$68

Medicaid work

$2,234 in 2024

Medicaid paid $2,234 for 21 billed services this clinician did in 2024, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES21$2,234
Medicaid work by year
202421112$2,234

Drugs they prescribed that Part D paid

$185,819

Pharmacies billed $185,819 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 126) in 2024. At or below the middle of the specialty; the typical hematopoietic cell transplantation and cellular therapy clinician is at 3%.

111 generic and 15 brand-name prescriptions · $185,819 in drug cost · 20 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Acyclovir26$774$30
Fluconazole13$763$59
Tacrolimus11$372$34
Sulfamethoxazole-Trimethoprim16$91$6
Prednisone15$17$1

Year by year

Part D prescribing by year
2024126200% (0)12%$185,819
202318916None14%$206,364
202271None0% (0)None$12,026
202164None0% (0)0%$2,143
2020186180% (0)None$24,320
201927020None9%$196,441
2018239230% (0)5%$54,804
201723120NoneNone$40,517
201616921NoneNone$6,836
201521829NoneNone$51,174
201427227None10%$54,172
2013110150% (0)None$34,273

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 5 drugs

Part D drugs prescribed in 2023
Fluconazole15$1,373$92
Acyclovir34$724$21
Triamcinolone Acetonide11$189$17
Sulfamethoxazole-Trimethoprim17$141$8
Trazodone11$124$11

2022: 1 drug

Part D drugs prescribed in 2022
Fluconazole12$1,205$100

2021: 4 drugs

Part D drugs prescribed in 2021
Fluconazole12$1,392$116
Tacrolimus13$296$23
Sulfamethoxazole-Trimethoprim17$88$5
Prednisone13$68$5

2020: 5 drugs

Part D drugs prescribed in 2020
Fluconazole12$1,087$91
Tacrolimus19$805$42
Acyclovir22$432$20
Sulfamethoxazole-Trimethoprim48$245$5
Prednisone28$161$6

2019: 7 drugs

Part D drugs prescribed in 2019
Acyclovir40$576$14
Tacrolimus13$388$30
Sulfamethoxazole-Trimethoprim41$260$6
Prednisone17$140$8
Famotidine12$108$9
Pantoprazole14$78$6
Fluconazole12$43$4

2018: 6 drugs

Part D drugs prescribed in 2018
Acyclovir37$715$19
Fluconazole16$533$33
Sulfamethoxazole-Trimethoprim40$173$4
Tamsulosin11$89$8
Prednisone17$68$4
Pantoprazole13$54$4

2017: 4 drugs

Part D drugs prescribed in 2017
Acyclovir30$381$13
Prednisone20$270$13
Sulfamethoxazole-Trimethoprim32$105$3
Pantoprazole16$67$4

2016: 5 drugs

Part D drugs prescribed in 2016
Acyclovir30$652$22
Gabapentin11$345$31
Pantoprazole21$193$9
Sulfamethoxazole-Trimethoprim28$192$7
Hydrochlorothiazide11$18$2

2015: 5 drugs

Part D drugs prescribed in 2015
Acyclovir49$1,228$25
Gabapentin11$264$24
Prednisone11$98$9
Sulfamethoxazole-Trimethoprim11$90$8
Hydrochlorothiazide12$60$5

2014: 6 drugs

Part D drugs prescribed in 2014
Atovaquone14$9,766$698
Acyclovir55$1,082$20
Pantoprazole23$269$12
Prednisone11$189$17
Famotidine22$165$7
Hydrochlorothiazide13$36$3

2013: 3 drugs

Part D drugs prescribed in 2013
Voriconazole11$14,473$1,316
Acyclovir17$428$25
Famotidine11$93$8

Money from drug and device companies

$10,419 in 2024

Industry payments by year
202429$9,218$10,419
202311None$22
202217$7,139$9,063
202135$5,210$5,379
202033$7,040$7,168
201915$5,500$6,048

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AmgenNone$10,119
8 payments
  • Consulting · 2024-09-17 · $8,918
  • Meals · 2024-09-17 · $41
  • Travel · 2024-09-17 · $68
  • Travel · 2024-08-09 · $249
  • Travel · 2024-08-08 · $212
  • Travel · 2024-08-08 · $249
  • Meals · 2024-08-08 · $59
  • Travel · 2024-06-13 · $323
ZOLL MedicalDefibrillator$300
1 payment
  • Consulting for Defibrillator · 2024-12-02 · $300
See all 9 published payments
Every published payment
ZOLL MedicalConsulting · 2024-12-02Defibrillator$300
AmgenConsulting · 2024-09-17None$8,918
AmgenMeals · 2024-09-17None$41
AmgenTravel · 2024-09-17None$68
AmgenTravel · 2024-08-09None$249
AmgenTravel · 2024-08-08None$212
AmgenTravel · 2024-08-08None$249
AmgenMeals · 2024-08-08None$59
AmgenTravel · 2024-06-13None$323
See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $22

Payments by company in 2023
Kite PharmaYescarta$22
1 payment
  • Meals for Yescarta · 2023-12-04 · $22

2022: $9,063

Payments by company in 2022
AmgenNone$9,063
7 payments
  • Travel · 2022-06-10 · $72
  • Consulting · 2022-06-10 · $7,139
  • Meals · 2022-06-10 · $42
  • Travel · 2022-04-27 · $1,075
  • Travel · 2022-04-27 · $184
  • Meals · 2022-04-27 · $208
  • Travel · 2022-04-27 · $342

2021: $5,379

Payments by company in 2021
Takeda Pharmaceuticals U.S.A.None$2,650
2 payments
  • Consulting · 2021-10-22 · $150
  • Consulting · 2021-09-08 · $2,500
Jazz PharmaceuticalsDefitelio$2,560
1 payment
  • Consulting for Defitelio · 2021-05-25 · $2,560
Coherus BiosciencesNone$169
2 payments
  • Meals · 2021-08-31 · $84
  • Meals · 2021-05-11 · $85

2020: $7,168

Payments by company in 2020
AmgenNone$4,400
1 payment
  • Consulting · 2020-12-07 · $4,400
Takeda Pharmaceuticals U.S.A.None$2,640
1 payment
  • Consulting · 2020-10-22 · $2,640
Coherus BiosciencesNone$128
1 payment
  • Meals · 2020-10-20 · $128

2019: $6,048

Payments by company in 2019
AmgenNone$6,048
5 payments
  • Consulting · 2019-10-25 · $5,500
  • Meals · 2019-08-03 · $135
  • Meals · 2019-08-02 · $84
  • Travel · 2019-08-02 · $255
  • Travel · 2019-08-02 · $74

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Adaptive Biotechnologies Corporation · Clonoseq · 2020Their institution$450

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1285791756
Licence
CA G55538California G55538: Current · expires 2027-03-31
Trained
Harvard Medical School, 1984
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0000X (207RH0000X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-01-03
NPI last updated
2024-04-15
NPI record certified
2024-04-15

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr.H3249, Mc 5623, Stanford, CA, 94305